Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 336

1.

A texting-based blood pressure surveillance intervention.

Zahr RS, Anthony CA, Polgreen PM, Simmering JE, Goerdt CJ, Hoth AB, Miller ML, Suneja M, Segre AM, Carter BL, Cavanaugh JE, Polgreen LA.

J Clin Hypertens (Greenwich). 2019 Sep 10. doi: 10.1111/jch.13674. [Epub ahead of print]

2.

Health sequelae of human cryptosporidiosis-a 12-month prospective follow-up study.

Carter BL, Stiff RE, Elwin K, Hutchings HA, Mason BW, Davies AP, Chalmers RM.

Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1709-1717. doi: 10.1007/s10096-019-03603-1. Epub 2019 Jul 14.

PMID:
31302785
3.

Effect of Dual-Carrier Processing on the Intelligibility of Concurrent Vocoded Sentences.

Apoux F, Carter BL, Healy EW.

J Speech Lang Hear Res. 2018 Nov 8;61(11):2804-2813. doi: 10.1044/2018_JSLHR-H-17-0234.

4.

Cluster-Randomized Trial to Evaluate a Centralized Clinical Pharmacy Service in Private Family Medicine Offices.

Carter BL, Levy B, Gryzlak B, Xu Y, Chrischilles E, Dawson J, Vander Weg M, Christensen A, James P, Polgreen L.

Circ Cardiovasc Qual Outcomes. 2018 Jun;11(6):e004188. doi: 10.1161/CIRCOUTCOMES.117.004188.

5.

Glimpsing speech in temporally and spectro-temporally modulated noise.

Fogerty D, Carter BL, Healy EW.

J Acoust Soc Am. 2018 May;143(5):3047. doi: 10.1121/1.5038266.

6.

Team-Based Care with Pharmacists to Improve Blood Pressure: a Review of Recent Literature.

Kennelty KA, Polgreen LA, Carter BL.

Curr Hypertens Rep. 2018 Jan 18;20(1):1. doi: 10.1007/s11906-018-0803-0. Review.

7.

Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease.

Anderegg MD, Gums TH, Uribe L, MacLaughlin EJ, Hoehns J, Bazaldua OV, Ives TJ, Hahn DL, Coffey CS, Carter BL.

Pharmacotherapy. 2018 Mar;38(3):309-318. doi: 10.1002/phar.2083. Epub 2018 Feb 23.

8.

Collaborative care model for hypertension.

Carter BL.

J Clin Hypertens (Greenwich). 2018 Jan;20(1):96-97. doi: 10.1111/jch.13142. Epub 2017 Dec 13. No abstract available.

9.

Selection bias and subject refusal in a cluster-randomized controlled trial.

Yang R, Carter BL, Gums TH, Gryzlak BM, Xu Y, Levy BT.

BMC Med Res Methodol. 2017 Jul 10;17(1):94. doi: 10.1186/s12874-017-0368-7.

10.

An algorithm to increase intelligibility for hearing-impaired listeners in the presence of a competing talker.

Healy EW, Delfarah M, Vasko JL, Carter BL, Wang D.

J Acoust Soc Am. 2017 Jun;141(6):4230. doi: 10.1121/1.4984271.

11.

The Clinical Pharmacy Specialist: Part of the Solution.

Rose AJ, McCullough MB, Carter BL, Rudin RS.

J Gen Intern Med. 2017 Apr;32(4):375-377. doi: 10.1007/s11606-016-3958-x. Epub 2016 Dec 19. No abstract available.

12.

Avoiding Pitfalls With Implementation of Randomized Controlled Multicenter Trials: Strategies to Achieve Milestones.

Carter BL, Ardery G.

J Am Heart Assoc. 2016 Dec 19;5(12). pii: e004432. Review. No abstract available.

13.

Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care.

Kulchaitanaroaj P, Brooks JM, Chaiyakunapruk N, Goedken AM, Chrischilles EA, Carter BL.

J Hypertens. 2017 Jan;35(1):178-187.

PMID:
27684354
14.

Research Needs to Improve Hypertension Treatment and Control in African Americans.

Whelton PK, Einhorn PT, Muntner P, Appel LJ, Cushman WC, Diez Roux AV, Ferdinand KC, Rahman M, Taylor HA, Ard J, Arnett DK, Carter BL, Davis BR, Freedman BI, Cooper LA, Cooper R, Desvigne-Nickens P, Gavini N, Go AS, Hyman DJ, Kimmel PL, Margolis KL, Miller ER 3rd, Mills KT, Mensah GA, Navar AM, Ogedegbe G, Rakotz MK, Thomas G, Tobin JN, Wright JT, Yoon SS, Cutler JA; National Heart, Lung, and Blood Institute Working Group on Research Needs to Improve Hypertension Treatment and Control in African Americans.

Hypertension. 2016 Nov;68(5):1066-1072. Epub 2016 Sep 12. Review. No abstract available.

15.

Physician-Pharmacist Collaborative Management: Narrowing the Socioeconomic Blood Pressure Gap.

Anderegg MD, Gums TH, Uribe L, Coffey CS, James PA, Carter BL.

Hypertension. 2016 Nov;68(5):1314-1320. Epub 2016 Sep 6.

16.

Primary Care Physician-Pharmacist Collaborative Care Model: Strategies for Implementation.

Carter BL.

Pharmacotherapy. 2016 Apr;36(4):363-73. doi: 10.1002/phar.1732. Epub 2016 Apr 6. Review.

PMID:
26931738
17.

Evolution of Clinical Pharmacy in the USA and Future Directions for Patient Care.

Carter BL.

Drugs Aging. 2016 Mar;33(3):169-77. doi: 10.1007/s40266-016-0349-2. Review.

18.

Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.

Isetts BJ, Buffington DE, Carter BL, Smith M, Polgreen LA, James PA.

Pharmacotherapy. 2016 Apr;36(4):374-84. doi: 10.1002/phar.1727. Epub 2016 Mar 18.

19.

Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.

Smith SM, Carris NW, Dietrich E, Gums JG, Uribe L, Coffey CS, Gums TH, Carter BL.

J Am Soc Hypertens. 2016 Apr;10(4):307-17. doi: 10.1016/j.jash.2016.01.010. Epub 2016 Jan 18.

20.

Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control.

Polgreen LA, Han J, Carter BL, Ardery GP, Coffey CS, Chrischilles EA, James PA.

Hypertension. 2015 Dec;66(6):1145-51. doi: 10.1161/HYPERTENSIONAHA.115.06023. Epub 2015 Nov 2.

21.

A Cluster-Randomized Trial of a Centralized Clinical Pharmacy Cardiovascular Risk Service to Improve Guideline Adherence.

Carter BL, Coffey CS, Chrischilles EA, Ardery G, Ecklund D, Gryzlak B, Vander Weg MW, James PA, Christensen AJ, Parker CP, Gums T, Finkelstein RJ, Uribe L, Polgreen LA; MEDication Focused Outpatient Care for Underutilization of Secondary Prevention Trial Investigators.

Pharmacotherapy. 2015 Jul;35(7):653-62. doi: 10.1002/phar.1603. Epub 2015 Jun 25.

22.

Pharmacist intervention for blood pressure control: medication intensification and adherence.

Gums TH, Uribe L, Vander Weg MW, James P, Coffey C, Carter BL.

J Am Soc Hypertens. 2015 Jul;9(7):569-78. doi: 10.1016/j.jash.2015.05.005. Epub 2015 May 15.

23.

Will Team-Based Care Really be Implemented?

Carter BL.

J Clin Hypertens (Greenwich). 2015 Sep;17(9):692-3. doi: 10.1111/jch.12578. Epub 2015 Jun 1. No abstract available.

24.

Sustained Blood Pressure Control Following Discontinuation of a Pharmacist Intervention for Veterans.

Carter BL, Vander Weg MW, Parker CP, Goedken CC, Richardson KK, Rosenthal GE.

J Clin Hypertens (Greenwich). 2015 Sep;17(9):701-8. doi: 10.1111/jch.12577. Epub 2015 Jun 1.

25.

A centralized cardiovascular risk service to improve guideline adherence in private primary care offices.

Carter BL, Levy BT, Gryzlak B, Chrischilles EA, Vander Weg MW, Christensen AJ, James PA, Moss CA, Parker CP, Gums T, Finkelstein RJ, Xu Y, Dawson JD, Polgreen LA.

Contemp Clin Trials. 2015 Jul;43:25-32. doi: 10.1016/j.cct.2015.04.014. Epub 2015 May 4.

26.

Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control.

Carter BL, Coffey CS, Ardery G, Uribe L, Ecklund D, James P, Egan B, Vander Weg M, Chrischilles E, Vaughn T.

Circ Cardiovasc Qual Outcomes. 2015 May;8(3):235-43. doi: 10.1161/CIRCOUTCOMES.114.001283. Epub 2015 Mar 24.

27.

Increasing trend in admissions for malignant hypertension and hypertensive encephalopathy in the United States.

Polgreen LA, Suneja M, Tang F, Carter BL, Polgreen PM.

Hypertension. 2015 May;65(5):1002-7. doi: 10.1161/HYPERTENSIONAHA.115.05241. Epub 2015 Mar 23.

PMID:
25801877
28.

Outpatient blood pressure monitoring using bi-directional text messaging.

Anthony CA, Polgreen LA, Chounramany J, Foster ED, Goerdt CJ, Miller ML, Suneja M, Segre AM, Carter BL, Polgreen PM.

J Am Soc Hypertens. 2015 May;9(5):375-81. doi: 10.1016/j.jash.2015.01.008. Epub 2015 Jan 21.

29.

A Systematic Review of Vancomycin Dosing and Monitoring in Burn Patients.

Carter BL, Damer KM, Walroth TA, Buening NR, Foster DR, Sood R.

J Burn Care Res. 2015 Nov-Dec;36(6):641-50. doi: 10.1097/BCR.0000000000000191. Review.

PMID:
25423436
30.

Effect of a care transition intervention by pharmacists: an RCT.

Farris KB, Carter BL, Xu Y, Dawson JD, Shelsky C, Weetman DB, Kaboli PJ, James PA, Christensen AJ, Brooks JM.

BMC Health Serv Res. 2014 Sep 18;14:406. doi: 10.1186/1472-6963-14-406.

31.

Instrumental variable methods to assess quality of care the marginal effects of process-of-care on blood pressure change and treatment costs.

Kulchaitanaroaj P, Carter BL, Goedken AM, Chrischilles EA, Brooks JM.

Res Social Adm Pharm. 2015 Mar-Apr;11(2):e69-83. doi: 10.1016/j.sapharm.2014.07.007. Epub 2014 Aug 1.

32.

Physician-pharmacist collaborative management of asthma in primary care.

Gums TH, Carter BL, Milavetz G, Buys L, Rosenkrans K, Uribe L, Coffey C, MacLaughlin EJ, Young RB, Ables AZ, Patel-Shori N, Wisniewski A.

Pharmacotherapy. 2014 Oct;34(10):1033-42. doi: 10.1002/phar.1468. Epub 2014 Aug 20.

33.

A mixed-method approach to evaluate a pharmacist intervention for veterans with hypertension.

Parker CP, Cunningham CL, Carter BL, Vander Weg MW, Richardson KK, Rosenthal GE.

J Clin Hypertens (Greenwich). 2014 Feb;16(2):133-40. doi: 10.1111/jch.12250.

34.

Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge.

Farley TM, Shelsky C, Powell S, Farris KB, Carter BL.

Int J Clin Pharm. 2014 Apr;36(2):430-7. doi: 10.1007/s11096-014-9917-x. Epub 2014 Feb 11.

35.

Efficacy and safety of nighttime dosing of antihypertensives: review of the literature and design of a pragmatic clinical trial.

Carter BL, Chrischilles EA, Rosenthal G, Gryzlak BM, Eisenstein EL, Vander Weg MW.

J Clin Hypertens (Greenwich). 2014 Feb;16(2):115-21. doi: 10.1111/jch.12238. Epub 2013 Dec 24. Review.

36.

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E.

JAMA. 2014 Feb 5;311(5):507-20. doi: 10.1001/jama.2013.284427. Erratum in: JAMA. 2014 May 7;311(17):1809.

PMID:
24352797
37.

Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension.

Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CV, Cohen DL, Cadet JC, Jean-Charles RR, Taler S, Kountz D, Townsend RR, Chalmers J, Ramirez AJ, Bakris GL, Wang J, Schutte AE, Bisognano JD, Touyz RM, Sica D, Harrap SB.

J Clin Hypertens (Greenwich). 2014 Jan;16(1):14-26. doi: 10.1111/jch.12237. Epub 2013 Dec 17. No abstract available.

38.

Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension.

Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CV, Cohen DL, Cadet JC, Jean-Charles RR, Taler S, Kountz D, Townsend R, Chalmers J, Ramirez AJ, Bakris GL, Wang J, Schutte AE, Bisognano JD, Touyz RM, Sica D, Harrap SB.

J Hypertens. 2014 Jan;32(1):3-15. doi: 10.1097/HJH.0000000000000065. No abstract available.

PMID:
24270181
39.

Underutilization of cardiovascular medications: effect of a continuity-of-care program.

Israel EN, Farley TM, Farris KB, Carter BL.

Am J Health Syst Pharm. 2013 Sep 15;70(18):1592-600. doi: 10.2146/ajhp120786.

40.

Similar blood pressure values across racial and economic groups: baseline data from a group randomized clinical trial.

Carter BL, Coffey CS, Uribe L, James PA, Egan BM, Ardery G, Chrischilles EA, Ecklund D, Vander Weg M, Vaughn T; Collaboration Among Pharmacists and Physicians to Improve Outcomes Now (CAPTION) trial investigators.

J Clin Hypertens (Greenwich). 2013 Jun;15(6):404-12. doi: 10.1111/jch.12091. Epub 2013 Apr 1.

41.

Institutional review board barriers and solutions encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now Study: a national multicenter practice-based implementation trial.

Maclaughlin EJ, Ardery G, Jackson EA, Ives TJ, Young RB, Fike DS, Carter BL.

Pharmacotherapy. 2013 Sep;33(9):902-11. doi: 10.1002/phar.1276. Epub 2013 May 3.

42.

Physician-pharmacist co-management and 24-hour blood pressure control.

Chen Z, Ernst ME, Ardery G, Xu Y, Carter BL.

J Clin Hypertens (Greenwich). 2013 May;15(5):337-43. doi: 10.1111/jch.12077. Epub 2013 Feb 12.

43.

Using theory to predict implementation of a physician-pharmacist collaborative intervention within a practice-based research network.

Demik DE, Vander Weg MW, Lundt ES, Coffey CS, Ardery G, Carter BL.

Res Social Adm Pharm. 2013 Nov-Dec;9(6):719-30. doi: 10.1016/j.sapharm.2013.01.003. Epub 2013 Mar 16.

44.

Acceptance of recommendations by inpatient pharmacy case managers: unintended consequences of hospitalist and specialist care.

Anderegg SV, Demik DE, Carter BL, Dawson JD, Farris K, Shelsky C, Kaboli P.

Pharmacotherapy. 2013 Jan;33(1):11-21. doi: 10.1002/phar.1164.

45.

Incremental costs associated with physician and pharmacist collaboration to improve blood pressure control.

Kulchaitanaroaj P, Brooks JM, Ardery G, Newman D, Carter BL.

Pharmacotherapy. 2012 Aug;32(8):772-80. doi: 10.1002/j.1875-9114.2012.01103.x.

46.

A Feasibility Study of Virtual Reality-Based Coping Skills Training for Nicotine Dependence.

Bordnick PS, Traylor AC, Carter BL, Graap KM.

Res Soc Work Pract. 2012 May;22(3):293-300.

47.

Guidelines for use of diuretics: a view from a member of JNC 7.

Carter BL.

J Clin Hypertens (Greenwich). 2012 May;14(5):273-6. doi: 10.1111/j.1751-7176.2012.00621.x. Epub 2012 Apr 11. No abstract available.

48.

Feasibility of Using Virtual Reality to Assess Nicotine Cue Reactivity During Treatment.

Kaganoff E, Bordnick PS, Carter BL.

Res Soc Work Pract. 2012 Mar 1;22(2):159-165.

49.

The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy.

Carter BL, Bosworth HB, Green BB.

J Clin Hypertens (Greenwich). 2012 Jan;14(1):51-65. doi: 10.1111/j.1751-7176.2011.00542.x. Epub 2011 Nov 28. Review.

50.

Affective reactivity during smoking cessation of never-quitters as compared with that of abstainers, relapsers, and continuing smokers.

Lam CY, Robinson JD, Versace F, Minnix JA, Cui Y, Carter BL, Wetter DW, Cinciripini PM.

Exp Clin Psychopharmacol. 2012 Apr;20(2):139-50. doi: 10.1037/a0026109. Epub 2011 Oct 31.

Supplemental Content

Loading ...
Support Center